do glp 1 cause anxiety GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective GLP-1s linked to lower rates

As demonstrated by oxyntomodulin, a weak endogenous agonist for GLP-1 receptor and glucagon receptor, a strategy that simultaneously stimulates both GLP-1 and glucagon receptors can reduce food intake while increasing energy expenditure, synergistically enhancing weight loss [105-107]

Moreover, the majority of these early non-responders (53-70%) fail to achieve clinically meaningful weight loss of 5% after six months of treatment

GLP-1 medications are recommended in the ADA Standards of Care for those with cardiovascular disease, heart failure, and/or kidney disease to reduce the risk of adverse events due to these conditions

Chip snacking among GLP-1 users has been trending down for the past year, but has managed to stay ahead of chocolate until this quarter

This can result in bloating and/or gastric discomfort